PubMed Health⌕ Search

Biomedical subjects

D Leahy

Publications and source records attributed to D Leahy.

7 recordsLinked to original sources
PubMed1996

Search for retrovirus in patients with multiple sclerosis.

Multiple sclerosis (MS) patient samples were screened for known or novel retroviruses using an ultrasensitive technique, IMx PERT, that detects the presence of reverse transcriptase (RT). This procedure has 10(5)- to 10(7)-fold greater sensitivity than conventional RT assays and is capable of detecting 10 to 50 virions. Moreover, IMx PERT is at least as sensitive as polymerase chain reaction, and requires no previous knowledge of viral nucleotide sequence. The MS specimens analyzed in this study included 136 sera from 79 patients and 128 cerebrospinal fluid samples from 53 patients with relapsing or chronic progressive disease. In addition, peripheral blood mononuclear cells from 19 MS patients were cultured in an attempt to amplify or induce expression of low-copy number or cell-associated retrovirus. No evidence of retrovirus was found in any of the specimens obtained from MS patients.

Base Sequence↗
PubMed1992

A novel semi-automated paramagnetic microparticle based enzyme immunoassay for hepatitis C virus: its application to serologic testing.

A new rapid serologic enzyme immunoassay for antibodies to hepatitis C virus (HCV) is described. The assay combines synthetic peptide and recombinant antigens representing putative structural and non structural HCV gene products with paramagnetic microparticle assay (MP assay) technology. Assay readout is based upon an enzymatically generated fluorescent product which is quantified with a novel semi-automated washer/reader instrument system. Assay sensitivity and specificity was determined to be greater than the first generation HCV C-100 EIA using a non-A, non-B hepatitis disease panel, an HCV performance panel, an HCV seroconversion panel, dilutions of HCV reactive sera, and random volunteer blood donor specimens.

Evaluation Studies as Topic↗
PubMed1991

In vitro studies of intestinal drug absorption. Determination of partition and distribution coefficients with brush border membrane vesicles.

Brush border membrane vesicles (BBMV) were isolated from rat small intestine and characterized in terms of relative enrichment of specific organelle marker enzymes (20-fold enrichment; 20% yield), contamination by other subcellular organelles (less than 1%) and functional integrity (Na(+)-dependent glucose uptake). Using these vesicles, techniques were developed for the determination of partition and distribution coefficients for the model solutes, nitrobenzene, toluene and benzoic acid. No gender, age or regional variation along the small intestine in partition coefficient (log P) values was detected. There was no temperature (10-40 degrees) or pH (4.5-8.0) dependence in partition coefficients of nitrobenzene and toluene. Fair agreement was obtained for log P and log D values for these two solutes determined with BBMV and those reported with octanol and propylene glycol dipelargonate. Selective removal of proteins, both ecto-brush border and micro-villus core proteins, did not alter the partition coefficients of the three model solutes. In contrast, depletion of the BBMV of non-esterified fatty acids significantly decreased the partition coefficients. Liposomes prepared from BBMV lipid extracts were also used for partition coefficient determinations and gave similar values to intact BBMV; addition of increasing amounts of cholesterol to the lipid extract caused small increases in the partition coefficients of the model solutes in the liposomes. It was concluded that the partition coefficients of the BBMV were related to the lipid and not to the protein composition of the vesicles. The method offers a rapid and reliable means of measuring the partition coefficient of non-protein bound drugs and nutrients in isolated intestinal BBMV and should assist in the subsequent modelling and prediction of intestinal absorption in vivo.

Animals↗
PubMed1987

Contribution of tryptophan residues to the combining site of a monoclonal anti dinitrophenyl spin-label antibody.

Two Fab fragments of the monoclonal anti dinitrophenyl (DNP) spin-label antibody AN02 were prepared by recombination of specifically deuterated heavy and light chains. In the recombinant H(I)L(II) all the tyrosines and phenylalanines were perdeuterated as were the tryptophan residues of the heavy chain. In the recombinant H(II)L(I) all the tyrosines and phenylalanines were perdeuterated as were the tryptophan residues of the light chain. Saturation of three resonances of H(I)L(II), assigned to tryptophan protons of the light chain, resulted in magnetization transfer to the aromatic proton at position 6 of the DNP ring and to the CH2 protons of the glycines linked to the DNP in a diamagnetic hapten (DNP-DG). Saturation of three resonances of H(II)L(I) assigned to tryptophan protons of the heavy chain resulted in magnetization transfer to the CH2 protons of the glycines in DNP-DG. From the dependence of the magnetization transfer on the irradiation time, the cross relaxation rates between the involved protons were estimated. The inferred distances between these protons of the hapten and certain tryptophan protons are 3-4 A. It is concluded that in the combining site of AN02 there is one tryptophan from the light chain and one tryptophan from the heavy chain that are very near the hapten. When all tyrosines and phenylalanines were perdeuterated and all tryptophan aromatic protons were deuterated except for the protons at positions 2 and 5, titration of the Fab fragments with variable amounts of paramagnetic hapten showed that one proton from the light chain tryptophan is near (less than 7 A) the unpaired electron and that three other protons are significantly closer than 15 A.(ABSTRACT TRUNCATED AT 250 WORDS)

Amino Acid Sequence↗
PubMedDate not supplied

Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences.

A paramagnetic microparticle (MP) assay for antibody to hepatitis C virus (anti-HCV) was developed, in which the probe for antibody consisted of synthetic peptides corresponding to HCV capsid and nonstructural c-100 regions, as well as a recombinant protein corresponding to the nonstructural c33c region. Assay performance was evaluated by testing serum from 108 geographically diverse patients with non-A, non-B hepatitis (NANBH). The frequency of anti-HCV reactivity detected with the MP assay and with an enzyme-linked immunosorbent assay (ELISA) for c-100 was 91 and 70 percent, respectively. All c-100 HCV ELISA-reactive specimens also reacted on the MP assay. In addition, anti-HCV seroconversion in three plasma donors was detected one to two blood collection dates earlier by the MP assay than by the c-100 HCV ELISA and at similar blood collection dates by the MP assay and a second-generation anti-HCV ELISA. Serologic responses to the three distinct antigenic regions of HCV in NANBH patients varied: reactivity to all three antigens was most common (49%), reactivity to both capsid and c33c (40%) was next most common, and single-antigen reactivity was rare (4%). MP assay reactivity of 825 volunteer donors was 0.1 percent. These results demonstrate both the utility of additional HCV antigens for an effective anti-HCV screening assay and the application of paramagnetic MP technology to serologic testing for HCV infection.

Antibody Specificity↗